A detailed history of Raymond James & Associates transactions in Prestige Consumer Healthcare Inc. stock. As of the latest transaction made, Raymond James & Associates holds 122,144 shares of PBH stock, worth $10.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
122,144
Previous 117,802 3.69%
Holding current value
$10.4 Million
Previous $8.11 Million 8.57%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$65.26 - $75.5 $283,358 - $327,821
4,342 Added 3.69%
122,144 $8.81 Million
Q2 2024

Jul 19, 2024

BUY
$62.62 - $71.76 $677,736 - $776,658
10,823 Added 10.12%
117,802 $8.11 Million
Q1 2024

Apr 22, 2024

BUY
$58.76 - $75.07 $372,185 - $475,493
6,334 Added 6.29%
106,979 $7.76 Million
Q4 2023

Jan 16, 2024

BUY
$57.0 - $61.94 $240,084 - $260,891
4,212 Added 4.37%
100,645 $6.16 Million
Q3 2023

Oct 24, 2023

BUY
$56.7 - $68.29 $22,339 - $26,906
394 Added 0.41%
96,433 $5.52 Million
Q2 2023

Jul 25, 2023

BUY
$56.28 - $63.76 $1.76 Million - $1.99 Million
31,216 Added 48.16%
96,039 $5.71 Million
Q1 2023

Apr 14, 2023

BUY
$58.41 - $67.05 $256,595 - $294,550
4,393 Added 7.27%
64,823 $4.06 Million
Q4 2022

Feb 08, 2023

SELL
$49.75 - $63.89 $99,102 - $127,268
-1,992 Reduced 3.19%
60,430 $3.78 Million
Q3 2022

Oct 25, 2022

BUY
$48.72 - $61.12 $2.75 Million - $3.45 Million
56,391 Added 935.02%
62,422 $3.11 Million
Q2 2022

Aug 12, 2022

SELL
$52.06 - $58.9 $171,537 - $194,075
-3,295 Reduced 35.33%
6,031 $355,000
Q1 2022

May 11, 2022

BUY
$52.94 - $61.88 $226,530 - $264,784
4,279 Added 84.78%
9,326 $494,000
Q4 2021

Feb 08, 2022

BUY
$55.41 - $63.3 $279,654 - $319,475
5,047 New
5,047 $306,000
Q3 2020

Nov 04, 2020

SELL
$34.54 - $40.79 $343,189 - $405,289
-9,936 Closed
0 $0
Q2 2020

Jul 28, 2020

SELL
$36.63 - $44.07 $2.16 Million - $2.6 Million
-58,925 Reduced 85.57%
9,936 $373,000
Q1 2020

Apr 21, 2020

SELL
$29.5 - $45.96 $287,507 - $447,926
-9,746 Reduced 12.4%
68,861 $2.53 Million
Q4 2019

Feb 12, 2020

SELL
$33.75 - $41.12 $62,302 - $75,907
-1,846 Reduced 2.29%
78,607 $3.18 Million
Q3 2019

Nov 07, 2019

BUY
$29.93 - $36.8 $1,885 - $2,318
63 Added 0.08%
80,453 $2.79 Million
Q2 2019

Aug 06, 2019

SELL
$27.65 - $31.68 $164,959 - $189,002
-5,966 Reduced 6.91%
80,390 $2.55 Million
Q1 2019

May 06, 2019

BUY
$26.79 - $31.72 $639,102 - $756,712
23,856 Added 38.17%
86,356 $2.58 Million
Q4 2018

Feb 11, 2019

SELL
$29.28 - $41.29 $29,309 - $41,331
-1,001 Reduced 1.58%
62,500 $1.93 Million
Q3 2018

Nov 14, 2018

BUY
$34.44 - $39.35 $631,560 - $721,600
18,338 Added 40.6%
63,501 $2.41 Million
Q2 2018

Aug 14, 2018

BUY
$28.49 - $38.41 $341,566 - $460,497
11,989 Added 36.14%
45,163 $1.73 Million
Q1 2018

May 14, 2018

SELL
$32.94 - $46.03 $387,868 - $542,003
-11,775 Reduced 26.2%
33,174 $1.12 Million
Q4 2017

Feb 14, 2018

SELL
$40.63 - $50.91 $6,744 - $8,451
-166 Reduced 0.37%
44,949 $2 Million
Q3 2017

Nov 13, 2017

SELL
$48.69 - $53.63 $13,048 - $14,372
-268 Reduced 0.59%
45,115 $2.26 Million
Q2 2017

Aug 14, 2017

BUY
N/A
45,383
45,383 $2.4 Million

Others Institutions Holding PBH

About Prestige Consumer Healthcare Inc.


  • Ticker PBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,762,600
  • Market Cap $4.22B
  • Description
  • Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...
More about PBH
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.